Mouse Paw Edema Induced by a Novel Bradykinin Agonist and Its Inhibition by B2-Antagonists.

DOI Web Site Web Site Web Site Web Site ほか1件をすべて表示 一部だけ表示 被引用文献3件 参考文献17件
  • Ueno Akinori
    Department of Pharmacology, School of Pharmaceutical Sciences, Kitasato University
  • Naraba Hiroaki
    Department of Pharmacology, School of Pharmaceutical Sciences, Kitasato University
  • Oh-ishi Sachiko
    Department of Pharmacology, School of Pharmaceutical Sciences, Kitasato University

書誌事項

タイトル別名
  • Mouse Paw Edema Induced by a Novel Brad

この論文をさがす

抄録

A novel non-peptide bradykinin B2-receptor agonist, FR190997 (8-[2, 6-dichloro-3-[N-[(E)4-(N-methylcarbamoyl)cinnamidoacetyl]-N-methylamino]benzyloxy]-2-methyl-4-(2-pyridylmethoxy) quinoline), induced dose-dependent and longer-lasting swelling than bradykinin in the mouse paw. The swelling, peaking around 30 min, was suppressed dose-dependently by intraperitoneal administration of FR173657, a novel non-peptide B2-receptor antagonist. A known B2-antagonist, Hoe 140, also significantly suppressed this edema. The result indicates that the novel B2-agonist FR190997, being more stable than bradykinin, could induce plasma exudation locally in mice via the B2-receptor as a substitute for bradykinin.

収録刊行物

  • Jpn.J.Pharmacol.

    Jpn.J.Pharmacol. 78 (1), 109-111, 1998

    公益社団法人 日本薬理学会

被引用文献 (3)*注記

もっと見る

参考文献 (17)*注記

もっと見る

詳細情報

問題の指摘

ページトップへ